company background image
IV3 logo

Invacare DB:IV3 Stock Report

Last Price

€0.45

Market Cap

€521.2k

7D

0%

1Y

-71.3%

Updated

01 May, 2023

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

IV3 Stock Overview

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. More details

IV3 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Invacare Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Invacare
Historical stock prices
Current Share PriceUS$0.45
52 Week HighUS$1.57
52 Week LowUS$0.30
Beta0.51
1 Month Change0%
3 Month Change-29.78%
1 Year Change-71.33%
3 Year Change-93.08%
5 Year Change-97.06%
Change since IPO-97.88%

Recent News & Updates

Recent updates

Shareholder Returns

IV3DE Medical EquipmentDE Market
7D0%-2.9%-2.6%
1Y-71.3%-8.5%6.9%

Return vs Industry: IV3 underperformed the German Medical Equipment industry which returned 6.7% over the past year.

Return vs Market: IV3 underperformed the German Market which returned -6.3% over the past year.

Price Volatility

Is IV3's price volatile compared to industry and market?
IV3 volatility
IV3 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: IV3's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine IV3's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
18852,800Geoff Purtillwww.invacare.com

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the Pin Dot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products.

Invacare Corporation Fundamentals Summary

How do Invacare's earnings and revenue compare to its market cap?
IV3 fundamental statistics
Market cap€521.16k
Earnings (TTM)-€91.83m
Revenue (TTM)€673.94m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IV3 income statement (TTM)
RevenueUS$741.73m
Cost of RevenueUS$557.69m
Gross ProfitUS$184.04m
Other ExpensesUS$285.12m
Earnings-US$101.07m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.66
Gross Margin24.81%
Net Profit Margin-13.63%
Debt/Equity Ratio436.8%

How did IV3 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/01 01:58
End of Day Share Price 2023/02/01 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Invacare Corporation is covered by 9 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LabickCJS Securities, Inc.
Constantine DavidesD. Boral Capital LLC.
Matthew MishanKeyBanc Capital Markets Inc.